*  Abstract 993: Trends in Racial Differences in the Use of Drug-Eluting Stents: Introduction and Diffusion | Circulation
Abstract 993: Trends in Racial Differences in the Use of Drug-Eluting Stents: Introduction and Diffusion. Saif S Rathore, ... Background: Drug-eluting stents (DES) were used less frequently among black patients when first introduced in 2003. It is ... Abstract 993: Trends in Racial Differences in the Use of Drug-Eluting Stents: Introduction and Diffusion ... Abstract 993: Trends in Racial Differences in the Use of Drug-Eluting Stents: Introduction and Diffusion ...
  http://circ.ahajournals.org/content/120/Suppl_18/S421.1
*  Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty - Full Text View - ClinicalTrials.gov
Device: Bare Metal Stent Device: Drug-Eluting Stent Drug: Blinded clopidogrel Drug: Placebo Drug: Thienopyridine (open-label) ... Device: Drug-Eluting Stent Patients receive one or more drug-eluting stents in the saphenous vein graft target lesion. ... bare metal stents (BMS) and drug-eluting stents (DES). Both BMS and DES are made of metal. DES are also coated with a drug that ... Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty (DIVA). The safety and scientific validity of ...
  https://clinicaltrials.gov/ct2/show/NCT01121224?term=cardiac+rehabilitation&recr=Open&fund=01&rank=8
*  Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty - Full Text View - ClinicalTrials.gov
Device: Bare Metal Stent Device: Drug-Eluting Stent Drug: Blinded clopidogrel Drug: Placebo Drug: Thienopyridine (open-label) ... Device: Drug-Eluting Stent Patients receive one or more drug-eluting stents in the saphenous vein graft target lesion. ... bare metal stents (BMS) and drug-eluting stents (DES). Both BMS and DES are made of metal. DES are also coated with a drug that ... Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty (DIVA). This study has been completed. ...
  https://clinicaltrials.gov/ct2/show/NCT01121224?term=heart+transplant+OR+cardiac+transplant&recr=Open&fund=01&rank=16
*  NewsCAP: Drug-eluting stents work as well as bare-metal ste... : AJN The American Journal of Nursing
NewsCAP: Drug-eluting stents work as well as bare-metal stents at keeping blocked arteries open. AJN The American Journal of ... Drug-eluting stents work as well as bare-metal stents at keeping blocked arteries open, according to a meta-analysis in the ... However, patients with drug-eluting stents required revascularization nearly half as often as those with bare-metal stents. The ... NewsCAP: Drug-eluting stents work as well as bare-metal stents at keeping blocked arteries open ...
  http://journals.lww.com/ajnonline/Fulltext/2012/07000/NewsCAP___Drug_eluting_stents_work_as_well_as.10.aspx
*  More Confirmation on Safety and Efficacy of Drug-Eluting Stents | Medpage Today
A pair of studies reported today provide additional evidence that drug-eluting stents have eclipsed bare-metal stents in both ... lower with drug-eluting stents than with bare-metal ones. The efficacy of drug-eluting stents has seldom been challenged -- ... in the drug-eluting stent arm versus 3.4%. Dr. Stone concluded that the use of a paclitaxel-eluting stent for primary ... Source Reference: James SK, et al "Long-term safety and efficacy of drug-eluting stents versus bare-metal stents in Sweden" N ...
  https://www.medpagetoday.com/cardiology/pci/14088
*  Drug-Eluting Stents: Boom or Bust? | Annals of Internal Medicine | American College of Physicians
PCI with drug-eluting stents reduced revascularizations, but not mortality or MI, compared with bare-metal stents Annals of ... PCI with drug-eluting stents reduced revascularizations, but not mortality or MI, compared with bare-metal stents Annals of ... PCI using drug-eluting stents had higher mortality than CABG in diabetes and multivessel CAD Annals of Internal Medicine; 158 ( ... PCI with drug-eluting stents ≤ 12 months before surgery was linked to increased MI and cardiac death after surgery Annals of ...
  http://annals.org/aim/article-abstract/1935058/drug-eluting-stents-boom-bust
*  Regarding Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft...
This is an interesting study showing a lower in-stent restenosis rate of patients receiving drug-eluting stents (DES) for ... 2008) Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft ... Regarding Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft ... Regarding Comparison of Percutaneous Coronary Intervention With Bare-Metal and Drug-Eluting Stents for Cardiac Allograft ...
  http://interventions.onlinejacc.org/content/2/5/474.2
*  Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis | Stroke
Background and Purpose- Intracranial stenting is associated with a 32% rate of restenosis. Drug-eluting stents (DES) have ... but has been effectively addressed by the use of drug-eluting stents (DES).2,3 These devices release drugs that prevent the ... Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis. Initial Experience and Midterm Angiographic Follow-up. ... Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol. 2005; 45: 954 ...
  http://stroke.ahajournals.org/content/36/12/e165
*  Abstract 2534: Long-term (up To 6 Years) Results Of Drug-eluting Stents For The Treatment Of Diabetic Patients - Insights From...
Results Of Drug-eluting Stents For The Treatment Of Diabetic Patients - Insights From The Drug Eluting Stents In The Real World ... Results Of Drug-eluting Stents For The Treatment Of Diabetic Patients - Insights From The Drug Eluting Stents In The Real World ... Results Of Drug-eluting Stents For The Treatment Of Diabetic Patients - Insights From The Drug Eluting Stents In The Real World ... Results Of Drug-eluting Stents For The Treatment Of Diabetic Patients - Insights From The Drug Eluting Stents In The Real World ...
  http://circ.ahajournals.org/content/118/Suppl_18/S_740.2
*  Drug-eluting stents - CRF
Drug-eluting Stents Drug-eluting Stents. The field of interventional cardiology has made great strides in developing innovative ... Today, approximately 75% of all stents placed during an angioplasty are drug-eluting stents. ... Drug-eluting stents are coated with medicine which is slowly released into the artery to help prevent re-blockages and repeat ... Stents are small wire mesh tubes that keep clogged arteries open after an angioplasty, a non-surgical procedure that opens up ...
  http://www.crf.org/crf/advancements/drug-eluting-stents
*  Drug-eluting stent thrombosis.
... drug-eluting stents (DES) are associated with a dramatic reduction in restenosis and target lesion revascularization. However, ... Drug-eluting stents in patients with end-stage renal disease.. Next Document: Antiplatelet therapy following drug-eluting stent ... When compared to bare metal stents (BMS), drug-eluting stents (DES) are associated with a dramatic reduction in restenosis and ... Drug-Eluting Stents / adverse effects*. Humans. Incidence. Risk Factors. From MEDLINE®/PubMed®, a database of the U.S. National ...
  http://www.biomedsearch.com/nih/Drug-eluting-stent-thrombosis/18432175.html
*  Drug Eluting Stents Have Delayed Adverse Events
... bleeding and cardiac problems than a bare metal coronary stent with continued thienopyridine. ... Drug eluting stents were better at preventing thrombosis, ... A drug eluting stent, a coronary stent placed into narrowed ... Drug Toxicity. Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, ... such as stent placement and 1 month of DAPT was compared with 6 to 12 months for drug-eluting stents (DES). ...
  http://www.medindia.net/news/drug-eluting-stents-have-delayed-adverse-events-147491-1.htm
*  Drug-Eluting Stent Update 2007 | Circulation
Drug-Eluting Stent Update 2007. Part I: A Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or ... Although only sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) have received US Food and Drug Administration ... In the Janus tacrolimus-eluting stent, the drug is embedded in reservoirs carved on the outer stent surface to release the drug ... Intracoronary Stenting and Angiographic Results-Drug-Eluting Stents for In-Stent Restenosis (ISAR-DESIRE) trial, and the ISAR- ...
  http://circ.ahajournals.org/content/116/3/316
*  Patent US7951193 - Drug-eluting stent - Google Patents
A stent for delivering therapeutic agents to a body lumen includes a plurality of circumferential serpentine bands with each ... Stent with thin drug-eluting film. EP1886703B1. 10 Jul 2007. 23 Jun 2010. BIOTRONIK VI Patent AG. Stent with a coating ... Drug-eluting stent for controlled drug delivery. US20040211362. 26 May 2004. 28 Oct 2004. Daniel Castro. System for coating a ... Drug-eluting stent for controlled drug delivery. US7163715. 30 Dec 2002. 16 Jan 2007. Advanced Cardiovascular Systems, Inc.. ...
  http://www.google.com.au/patents/US7951193
*  Drug-Eluting Stents I
... a.k.a drug coated stents or medicated stents or DES) which explains the basics about these devices, including key vocabulary, ... For more in-depth information and late-breaking articles about drug-eluting stents, visit our Drug-Eluting Stent Center. ... 1) An introduction to drug-eluting stents (also known as "drug coated stents", "medicated stents", or "DES");. (2) A history of ... Drug-eluting stents are metal stents that have been coated with a pharmacologic agent (drug) that is known to suppress ...
  http://www.ptca.org/des.html
*  Nanoparticles - possible alternative to drug eluting stents
... By Massachusetts Institute of Technology, Jan 18, 2010 - 2:00:58 ... an advance that potentially provides an alternative to drug-releasing stents in some patients with cardiovascular disease.. The ... The drug can only be released when it detaches from the PLA polymer chain, which occurs gradually by a reaction called ester ... So far, they have achieved drug release over 12 days, in tests in cultured cells.. In tests in rats, the researchers showed ...
  http://www.rxpgnews.com/coronaryarterydisease/Nanoparticles_-_possible_alternative_to_drug_eluting_stents_printer.shtml
*  Drug-Eluting Stent and Coronary Thrombosis | Circulation
In sirolimus-eluting stents, ≈80% of the rapamycin has eluted by 30 days, whereas paclitaxel-eluting stents have a biphasic ... Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol. 2005; 45: 2088-2092. ... Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J ... Since the introduction of drug-eluting stents (DES), most interventional centers have noted stent thrombosis up to 3 years ...
  http://circ.ahajournals.org/content/115/8/1051.full
*  Drug Eluting Stent
... Ultimaster® - Drug eluting stent. Pushing the boundaries of science and medical engineering for the ... combines an optimal balance between stent design for ultimate conformability with simultaneous polymer resorption and drug ...
  http://www.terumo-europe.com/en-emea/interventional-cardiology/stents/drug-eluting-stent/
*  Drug eluting stents do make for better angioplasty outcomes - Thaindian News
... researchers found that patients receiving drug eluting stents (DES) stents coated with medication to prevent narrowing of the ... "Our study findings suggest that drug eluting stents, despite recent concerns surrounding drug eluting stent safety, the long- ... Washington, Dec 19 (ANI): In a new study, researchers found that patients receiving drug eluting stents (DES) stents coated ... Drug eluting stents do make for better angioplasty outcomes. December 19th, 2008 - 5:23 pm ICT by ANI Tweet. ...
  http://www.thaindian.com/newsportal/health/drug-eluting-stents-do-make-for-better-angioplasty-outcomes_100132831.html
*  PNAS: Nanoparticles could eliminate drug-eluting stents | Health Imaging
... which could be an alternative to drug-eluting stents in some patients with cardiovascular disease, according to research ... which could be an alternative to drug-eluting stents in some patients with cardiovascular disease, according to research ... which was loaded with slow-eluting conjugates of paclitaxel for controlled drug release over 12 days.. "This is a very exciting ... Because the particles can deliver drugs over a longer period of time and can be injected intravenously, patients would not have ...
  http://www.healthimaging.com/topics/molecular-imaging/pnas-nanoparticles-could-eliminate-drug-eluting-stents
*  Patent US8128687 - Drug-eluting stent with filament strands - Google Patents
... polymeric sleeve for controlled release of therapeutic drugs and for delivery of the therapeutic drugs in localized drug ... The stent has a high degree of flexibility in the longitudinal direction, yet has adequate vessel wall coverage and radial ... attached to an outer surface of a stent structure in a spaced apart orientation and loaded with at least one therapeutic drug ... The polymeric sleeve is attached to at least a portion of an outside surface area of the stent structure. Alternatively, a ...
  http://www.google.co.uk/patents/US8128687
*  New Generation Drug-Eluting Stent Shows Equivalent Efficacy | EmaxHealth
... time that a drug-eluting stent with a biodegradable polymer is just as safe and effective as a conventional drug-eluting stent ... First-generation drug-eluting stents released the drug from a durable polymer, which may be associated with the formation of ... of patients in the biolimus-eluting stent group and 10.5% of patients in the sirolimus-eluting stent group). In the one in four ... The drug-eluting stent is designed to treat narrowing of coronary arteries which is one of the principal causes of coronary ...
  https://www.emaxhealth.com/24/1/24400.html
*  In Acute MI, Drug-Eluting Stents Hold Modest Survival Advantage | Medpage Today
Drug-eluting stents appear safer for acute MI patients in real-world practice than do bare-metal devices, researchers said. ... sirolimus-eluting stents [Cypher], 27% paclitaxel-eluting stents [Taxus], and 2% both). Drug-eluting stents were associated ... See: ACC: Drug-Eluting Stent Safety for Acute MI Seen in Real World Practice) These advantages for drug-eluting stents were ... In Acute MI, Drug-Eluting Stents Hold Modest Survival Advantage. BOSTON -- Drug-eluting stents appear safer for acute MI ...
  https://www.medpagetoday.com/cardiology/pci/11051
*  Drug eluting stents used less often in women than men
Drug eluting stents (DES) are used less often in women treated with percutaneous coronary intervention (PCI) for coronary ... During treatment with PCI, cardiologists can use bare metal stents (BMS) or the newer DES. While they do not reduce mortality, ... included 100,704 stent implantations between 2005 and 2009. The data revealed that women received a lower percentage of DES for ...
  https://www.mdtmag.com/news/2012/08/drug-eluting-stents-used-less-often-women-men
*  Dual Antiplatelet Therapy Duration in Patients With Drug-Eluting Stents
... drug-eluting stents. To prevent progressive atherosclerosis in the case of drug-eluting stents, current guidelines suggest a ... Compared with sirolimus-eluting stents, everolimus-eluting stents resulted in longer-term reduction of the risk of stent ... and stent procedures using drug-eluting stents (DES) or bare metal stents (BMS). This article will focus on background ... Drug-eluting coronary-artery stents. New Engl J Med. 2013;368:254-265.. 7. Levin T, Cutlip D. General principles of the use of ...
  https://www.uspharmacist.com/article/dual-antiplatelet-therapy-duration-in-patients-with-drugeluting-stents